文献速递免疫规划传染病防控与疫情报告

日本实施两剂水痘疫苗普遍接种4年后患者趋势

Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan.
PubMed 文献 · Vaccine · 2020-09-30

研究分析了2015年9月至2019年8月名古屋14家儿科诊所15岁以下疑似水痘患者,分子诊断确诊506例(83.1%)。普遍接种目标组2016/17季季节性流行消失,非目标组2017/18季也模糊;患者以非目标组为主,尤其单剂接种者占60.4%。

要点

  • 普遍接种后儿童水痘患者数逐渐下降,但非目标组仍见局部暴发。
  • 非目标组患者年龄较大,发热和皮疹数量显著高于目标组。
  • 单剂接种是非目标组患者的主要疫苗接种状态(60.4%)。

核心结论

  • 实施两剂水痘疫苗国家免疫规划后儿童水痘患者减少,但非普遍接种目标组仍发生局部暴发。
  • 该组疫苗接种不足可能是小规模局部暴发的主要原因。

研究设计与样本

  • 研究纳入2015年9月至2019年8月名古屋VZV研究组14家儿科诊所就诊的15岁以下疑似水痘患者。
  • practitioners收集样本与信息,所有患者经分子诊断确诊,共506例(83.1%)检出VZV DNA。
  • 有疫苗接种状态的455例患者分为普遍接种目标组(180例)和非目标组(275例)。

主要发现

  • 观察期间每月水痘患者数逐渐下降。
  • 2016/17季普遍接种目标组季节性流行不可检测,2017/18季起非目标组也模糊。
  • 目标组患者中位年龄3岁显著低于非目标组7岁(P < 0.001)。
  • 两组疫苗接种状态差异显著(P < 0.001),非目标组患者多数曾接种一剂(60.4%)。
  • 非目标组首次就诊时发热频率(P < 0.001)和皮疹数量(P = 0.001)显著更高。

关键数值与推荐

  • 609例疑似患者中506例(83.1%)检出VZV DNA。
  • 455例有疫苗接种状态者中,目标组180例,非目标组275例。
  • 非目标组中单剂接种者占60.4%。

临床怎么用

  • 应关注非普遍接种目标组儿童的水痘疫苗接种状态,尤其单剂接种者。
  • 对较大年龄儿童及疫苗接种不全者保持水痘监测和补种提醒。

局限性

  • 研究仅纳入名古屋14家儿科诊所的就诊患者,代表性有限。
  • 仅455例有疫苗接种状态信息,可能存在信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To elucidate the trend and clinical spectrum of virologically diagnosed varicella patients after implementation of universal vaccination as a national immunization program in Japan. PATIENTS AND METHODS: Study subjects were patients suspected of varicella, less than 15 years of age, who visited 14 pediatric clinics in the Nagoya VZV Study Group from September 2015 to August 2019. Practitioners collected patient samples and information such as backgrounds, clinical symptoms, and previous immunization status. All patients were confirmed as having varicella based on molecular diagnostic assays. RESULTS: Varicella zoster virus (VZV) DNA was detected in swab samples from 506 (83.1%) of the 609 suspected patients. The 455 varicella patients for whom vaccination status was available were divided into two groups: 180 universal vaccination targets and 275 non-targets. Numbers of monthly varicella patients decreased gradually during the observation period. In the 2016/17 season, the seasonal epidemic of varicella became undetectable in the universal vaccination target group, and starting in the 2017/18 season, it was obscured even in the non-target group. The median age of patients was significantly lower in the universal vaccination target group (3 years) than the non-target group (7 years) (P < 0.001). Vaccination status differed significantly between the two groups (P < 0.001). Most varicella patients were in the non-target group, especially those who had been vaccinated once (60.4%). Frequency of fever (P < 0.001) and number of skin rashes at the time of the first hospital visit (P = 0.001) were significantly higher in the non-target group. CONCLUSIONS: Although the number of childhood varicella patients declined after implementation of national immunization with two doses of varicella vaccination, sporadic outbreaks still occurred, mainly in the non-universal vaccination target group. Insufficient vaccination of members of this group is likely to be a major reason for small local outbreaks.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hattori F, Kozawa K, Miura H, et al. Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan. Vaccine. 2020. PMID: 33008671. doi:10.1016/j.vaccine.2020.09.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。